MedTrace Logo

Changes in Body Composition After EPA Supplementation in Head and Neck Patients

NCT02715596 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2019-09-04

No results posted yet for this study

Summary

Evaluates the effect of EPA supplementation in terms of muscle mass in patients with squamous cell carcinoma of the head and neck locally advanced

Conditions

  • Squamous Cell Carcinoma of Head and Neck

Interventions

DIETARY_SUPPLEMENT

EPA supplementation

2.7 g EPA supplementation in a 15 cc emulsion stick-pack

OTHER

Placebo

placebo in 15 cc emulsion stick-pack

Sponsors & Collaborators

  • Ferrer Internacional S.A.

    collaborator INDUSTRY

  • Institut Català d'Oncologia

    lead OTHER

Principal Investigators

  • Lorena Arribas, RD, MsC · Institut Català d'Oncologia

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-23
Primary Completion
2019-03-01
Completion
2019-09-02

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02715596 on ClinicalTrials.gov